On the contrary, FAS expression was upregulated in tumour 14 (PAP60) compared with the receptor downregulation observed in tumour 15 (MIH55), which also correlated to the increased sensitivity of PAP60 tumour-derived cells to FASL. The gene discussed is FASLG; the disease is neoplasm.